Yes because of COVID.
Hence why Q4 FY21 is the benchmark for comparison not Q1 FY22 like you're being suckered into believing. The market was kind to LYC in Q1 FY22 because of COVID impacting production so much so they let it slide. Now LYC is performing 11% better in revenue at full capacity when compared to Q4FY21... That's REALLY BAD when the share price is up 70% and NdPr is up +30% as well.... A terrible, terrible result given the share price.
Ann: Quarterly Activities Report, page-17
Add LYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.40 |
Change
0.170(2.73%) |
Mkt cap ! $5.982B | |||
| Open | High | Low | Value | Volume |
| $6.34 | $6.40 | $6.28 | $12.65M | 1.991M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 15037 | $6.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.40 | 38814 | 10 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| LYC (ASX) Chart |